Premium
Letter: infliximab therapy for patients with inflammatory bowel disease – some unanswered questions
Author(s) -
Srinivas N. R.
Publication year - 2015
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13385
Subject(s) - infliximab , medicine , dosing , inflammatory bowel disease , population , trough (economics) , trough concentration , disease , gastroenterology , surgery , environmental health , economics , macroeconomics